Uptake of hormonal implants contraceptives compared to other forms of contraceptives in Abuja, Nigeria


  • Malachy E. Ayogu Department of Obstetrics and Gynecology, University of Abuja Teaching Hospital, Abuja, Nigeria
  • Chibuzor C. Eruemulor Department of Obstetrics and Gynecology, University of Abuja Teaching Hospital, Abuja, Nigeria
  • Augustine O. Olibe Department of Obstetrics and Gynecology, University of Nigeria Teaching Hospital, Ituku -Ozalla, Enugu, Nigeria




Contraceptive, Uptake, Discontinuation, Implants, Subdermal


Background: Subdermal implants are a long-term, efficacious, and easily reversible contraceptive with few adverse effects that pose no risk to the health of the users. It is increasingly accepted as a method of contraception in sub-Sahara Africa like ours. Despite this, its uptake in Nigeria has not reached optimum level. This study is aimed at evaluating the socio-demographic characteristics of subdermal implants users in Abuja, Nigeria, its acceptance rate, efficacy, and discontinuation rate.

Methods: The case notes of all the women from the family planning unit were studied. Data on socio-demographic characteristics, uptake rate, side effects profile and the discontinuation rates between January 2013 and December 2017 were retrieved and analyzed using SPSS software and results expressed in numbers and percentages

Results: Out of a total of 1,716 clients that were for contraception during the period under review, 786 accepted Jadelle/Implanon accounting for 45.8% of the implants acceptance rate. Of the 786 acceptors, 485(28.3%) chose Implanon, whereas 301(17.5%) preferred Jadelle. Discontinuation rate for both implants was 20.7%; the main reasons cited by the women were desire to have more children; 51(31.35%) and irregular vaginal bleeding; 30(18.4%). The Pearl Index for the implants in the study was zero. The peak parity for implant users was para 3. Approximately 72.1% the users of all forms of contraception were Christians, while 25.4% were Muslims. About 74.0% of the users had tertiary education.

Conclusions: Jadelle/Implanon uptake was relatively high compared to other forms of contraception.


National population commission and ICF Macro. Nigeria Demographic and Health Survey; Calcertom (Maryland) National Population Commission and ICF Macro. 2013;11-29.

Monjok E, Smesny A, Ekabua JE, Essien EJ. Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions. Open access J contracep. 2010;1:9.

Egede JO, Onoh RC, Umeora OU, Iyoke CA, Dimejesi IB, Lawani LO. Contraceptive prevalence and preference in a cohort of south–east Nigerian women. Patient preference and adherence. 2015;9:707.

Madugu NH, Abdul MA, Bawa U, Kolawole B. Uptake of hormonal implants contraceptive in Zaria, Northern Nigeria. Open J Obstetr Gynecol. 2015;5(05):268.

Adeyemi AS, Owonikoko KM, Adekanle DA, Aworinde O. Subdermal contraceptive implants: Experience at a tertiary health institution in Southwestern Nigeria. Sahel Med J. 2018;21(3):137.

Kolawole OO, Sowemimo OO, Ojo OO, Fasubaa OB. Contraceptive implants: A review and current perspective in southwest Nigeria. Trop J Obstetr Gynaecol. 2018;35(2):108-12.

Pam VC, Mutihir JT, Nyango DD, Shambe I, Egbodo CO, Karshima JA. Sociodemographic profiles and use-dynamics of Jadelle (levonorgestrel) implants in Jos, Nigeria. Nigerian medical journal: J Nigeria Med Associat. 2016;57(6):314.

Funk S, Miller MM, Mishell Jr DR, Archer DF, Poindexter A, et al. Implanon™ US Study Group. Safety and efficacy of Implanon™, a single-rod implantable contraceptive containing etonogestrel. Contracept. 2005;71(5):319-26.

Adams K, Beal MW. Implanon: a review of the literature with recommendations for clinical management. J midwifery women's health. 2009;54(2):142-9.

Ohihoin GA, Bello B, Herbertson EC, Ezechi OC. Use of modern contraceptive implants the: Lagos island maternity Hospital experience. Trop J Obstetr Gynaecol. 2015;32(2):125-31.

Balogun OR, Olaomo N, Adeniran AS, Fawole AA. Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria. J Med Biomed Sci. 2014;3(1):1-5.

Oladipo OA, Akinso SA. Contraceptive implants. Afr J Reprod Health 2005:16-23.

Ojule JD, Macpepple DA. Family planning practice in a tertiary health institution in Southern Nigeria. West Afri J med. 2011;30(3):178-81.

Abasiattai AM, Bassey EA, Udoma EJ. Profile of intrauterine contraceptive device acceptors at the University Uyo Teaching Hospital, Uyo, Nigeria. Annals of Afri Med. 2008;7(1):1-5.

Hardee K, Leahy E. Population, fertility and family planning in Pakistan: a program in stagnation. Population Action Intern. 2008;3(3):1-2.

Moodley A, Mahomed O. Prevalence and predictors of Implanon uptake in Ugu (Ugu North Sub District) 2016/17. South African Family Practic. 2019;61(2):48-52.

Ojule JD, Oranu EO, Enyindah CE. Experience with Implanon in Southern Nigeria. J Med Med Sci. 2012;3(11):710-4.

Tsui AO, Brown W, Li Q. Contraceptive practice in sub-Saharan Africa. Population and development review. 2017;43(1):166.

Rees H, Pillay Y, Mullick S, Chersich MF. Strengthening implant provision and acceptance in South Africa with the ‘Any woman, any place, any time’approach: An essential step towards reducing unintended pregnancies. South Afri Med J. 2017;107(11):939-44.

Scherwitzl EB, Lundberg O, Kallner HK, Danielsson KG, Trussell J, Scherwitzl R. Perfect-use and typical-use Pearl Index of a contraceptive mobile app. Contraception. 2017;96(6):420-5.




How to Cite

Ayogu, M. E., Eruemulor, C. C., & Olibe, A. O. (2019). Uptake of hormonal implants contraceptives compared to other forms of contraceptives in Abuja, Nigeria. International Journal of Research in Medical Sciences, 7(12), 4557–4562. https://doi.org/10.18203/2320-6012.ijrms20195518



Original Research Articles